Steris (STE) Capital Expenditures (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.61% |
| Dec 31, 2025 | 14.10% |
| Sep 30, 2025 | -7.59% |
| Jun 30, 2025 | 32.03% |
| Mar 31, 2025 | -20.53% |
| Dec 31, 2024 | -12.46% |
| Sep 30, 2024 | -5.74% |
| Jun 30, 2024 | 18.15% |
| Mar 31, 2024 | -23.07% |
| Dec 31, 2023 | 42.79% |
| Sep 30, 2023 | 25.06% |
| Jun 30, 2023 | -6.79% |
| Mar 31, 2023 | -22.18% |
| Dec 31, 2022 | 10.94% |
| Sep 30, 2022 | -28.61% |
| Jun 30, 2022 | 58.66% |
| Mar 31, 2022 | -9.92% |
| Dec 31, 2021 | 5.39% |
| Sep 30, 2021 | 36.49% |
| Jun 30, 2021 | -24.57% |
| Mar 31, 2021 | 39.10% |
| Dec 31, 2020 | 22.48% |
| Sep 30, 2020 | -34.36% |
| Jun 30, 2020 | 9.85% |
| Mar 31, 2020 | 9.71% |
| Dec 31, 2019 | 14.69% |
| Sep 30, 2019 | -2.85% |
| Jun 30, 2019 | -34.89% |
| Mar 31, 2019 | 50.88% |
| Dec 31, 2018 | 45.56% |
| Sep 30, 2018 | 25.60% |